Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation

Neurological Research
Jeyarama S AnantaTarik F Massoud

Abstract

Current chemotherapies for brain glioblastoma do not achieve sufficient drug concentrations within tumors. Polymeric nanoparticles have useful physicochemical properties that make them promising as nanoparticle platforms for glioblastoma drug delivery. Poly[lactic-co-glycolic acid] (PLGA) nanoparticles encapsulating temozolomide (TMZ) could improve localized delivery and sustained drug release to glioblastomas. We investigated three different procedures to encapsulate TMZ within PLGA nanoparticles. We studied the biophysical features of optimized nanocarriers, including their size, shape, surface properties, and release characteristics of TMZ. We evaluated the antiproliferative and cytotoxic effects of TMZ-loaded PLGA nanoparticles on U87 MG glioblastoma cells. A single emulsion technique using a TMZ saturated aqueous phase produced nanoparticles ≤200 nm in size allowing a maximal drug loading of 4.4% w/w of polymer. There was a bi-phasic drug release pattern, with 80% of TMZ released within the first 6 h. Nanoparticles accumulated in the cytoplasm after effective endocytosis. There was no significant difference in cytotoxic effect of TMZ encapsulated within PLGA nanoparticles and free TMZ. PLGA nanoparticles are not suitable a...Continue Reading

References

Jan 1, 1988·Journal of Neurosurgery·P L Kornblith, M Walker
Nov 1, 1995·Journal of Neuro-oncology·T F Cloughesy, K L Black
Apr 13, 2001·Drug Discovery Today·W M. Pardridge
Jul 18, 2002·Nature Reviews. Drug Discovery·William M Pardridge
Apr 5, 2003·Journal of Neuro-oncology·Mahendra PatelFrank M Balis
Dec 4, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paul R LockmanDavid D Allen
Dec 3, 2003·Journal of Neuro-oncology·Michael Weaver, Douglas W Laske
Mar 3, 2004·Molecular Interventions·William M Pardridge
Sep 24, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joanna M KoziaraRussell J Mumper
Sep 27, 2006·International Journal of Pharmaceutics·He Zhang, Shen Gao
Oct 20, 2006·Journal of Pharmaceutical Sciences·Fu-de CuiKai Shi
Nov 17, 2006·Advanced Drug Delivery Reviews·Yong-Eun Lee KooRaoul Kopelman
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Sep 23, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Karsten UlbrichJörg Kreuter
Oct 14, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Einat Cohen-SelaGershon Golomb
Nov 4, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Daniel MorenoMaría J Garrido
Apr 30, 2010·International Journal of Oncology·Atsuo YoshinoKouhei Tsumoto
Oct 18, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·M VerreaultM B Bally
Dec 17, 2011·Journal of Drug Delivery·Ruben J Boado, William M Pardridge
Oct 30, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ashlee N Ford VersyptRichard D Braatz
Nov 8, 2012·Clinical & Developmental Immunology·Sadhak SenguptaPrakash Sampath

❮ Previous
Next ❯

Citations

Jan 25, 2018·International Journal of Molecular Sciences·Nausicaa ClementeChiara Dianzani
Feb 16, 2019·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Daniel A Rodriguez de AndaSue Anne Chew
Mar 3, 2020·Frontiers in Bioengineering and Biotechnology·Divesha EssaViness Pillay
Mar 7, 2017·Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology·Antonio Di MartinoVladimir Sedlarik
Nov 20, 2018·Frontiers in Pharmacology·Sima RezvantalabFabian Kiessling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.